Anthony D. Cristillo
Anthony D. Cristillo obtained his B.S. (with Honors) and Ph.D. degrees in molecular biology/biochemistry from Queen’s University, Kingston, ON, Canada. His doctoral work summarized the characterization of immediate-early genes involved in T-cell activation and the bioinformatic analyses of different viral genomes to identify mechanisms of viral latency. He completed a postdoctoral fellowship in molecular and cellular immunology at the National Institutes of Health, Bethesda, MD, USA, and studied regulation of the principle human immunodeficiency virus 1 (HIV-1) coreceptor on T lymphocytes, CXCR4, as well as T-cell signaling pathways. Dr. Cristillo earned an M.S. degree in information systems technology from George Washington University, Washington, USA, and continued his research on T-cell signaling pathways using bioinformatics in conjunction with cDNA microarray analysis. Following his postdoctoral fellowship, he joined Advanced BioScience Laboratories in Rockville, MD, USA, to focus on the design and development of HIV vaccine candidates. He currently serves as the Director of Immunobiology at ABL, Inc., and oversees the immunological evaluation of both vaccines and therapeutics targeting infectious disease and cancer in small and large animal models as well as human clinical trials. Dr. Cristillo is also an Adjunct Professor at the University of Maryland University College in Adelphi, MD, USA.
Biography Updated on 27 November 2014